Back to mobile site

More on GELS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings

Upcoming Events

- Earnings (9/29/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Gelteq Limited (NQ:GELS)
Delayed: 0.99 -0.54 (35.29%)
Prev. Close $1.53  
Open$0.94 
52 Wk High$ 
52 Wk Low$ 
Day High$1.13 
Day Low$0.88 
P/E N/A  
EPS$ 
Volume6,170,662 

Friends, Peers and Foes (?): HYEX, AMZE, CHCI, FET, HSCS (more...)

Jun 12, 2026 12:30 PM Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications
Jun 4, 2026 09:08 AM Gelteq opens China center to boost drug development operations
Jun 4, 2026 09:08 AM Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion
Jun 2, 2026 04:05 PM Form 6-K Gelteq Ltd For: Jun 02
May 26, 2026 04:14 PM Form 6-K Gelteq Ltd For: May 26
May 20, 2026 08:01 AM Gelteq begins veterinary clinical trial for antiparasitic drug candidate
May 20, 2026 08:00 AM Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
May 14, 2026 08:42 AM Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA
May 12, 2026 08:03 AM Gelteq secures $3.5 million debt financing for commercialization
May 12, 2026 08:00 AM Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth
View All Articles

Entities mentioned with GELS

View All Entities